Change in Management Board of Heraeus Medical 

Wehrheim, December 12, 2024 – Nicole Petermann, Co-President of Heraeus Medical, will hand over the management of the company to Arthur Charlet, effective January 1st, 2025. As second Managing Director he will assume the company’s leadership together with Dr. Andrew Williamson who is Co-President since 2019 already.

Nicole Petermann is leaving the company at the end of December at her own request and for personal reasons.

Nicole Petermann has been Co-President of Heraeus Medical since 2019 and on the Board of Managing Directors of Heraeus Medical since 2017. She joined Heraeus Medical in 2008 as Head of Finance and became Head of Finance & Commercial Services in 2010.

Under the co-leadership of Nicole Petermann and Dr. Andrew Williamson Heraeus Medical has strengthened its market leading position and has developed into a truly dominant global business with a strong direct footprint. In addition to geographic expansion Heraeus Medical focused on organic innovation. Intense R&D activities resulted in innovative new products and the envisaged portfolio transition towards Simplification and Infection Management.

“With her communicative and team-oriented management style Nicole Petermann has strongly shaped Heraeus Medical and continuously driven the excellent growth and success of the company. Through her dedication the company has become a global market leader in Orthobiologics and has positioned itself for further growth and is today far ahead of the industry in many important areas such as customer orientation, quality standards, regulatory approvals, diversity and sustainability. I would like to thank Nicole Petermann for her outstanding commitment and wish her all the best for the future,” said Jan Rinnert, CEO and Chairman of the Board of Managing Directors of the Heraeus Group.

Arthur Charlet joined Heraeus in February 2012 and started his career as a trainee in Finance/Controlling. After working in project controlling at Heraeus Electronics and in M&A and strategy, he took over as Head of Finance of Heraeus Comvance in 2021. Since September 2023, he has been Group Senior Vice President Sustainability, where he is responsible for the topic of sustainability within the Heraeus Group.

“I am pleased that we have found an internal successor for the position of Co-President of Heraeus Medical in Arthur Charlet. With his expertise and leadership skills, he will accompany Heraeus Medical, a leading company in the field of bone cements and biomaterials for orthopedics and trauma surgery, into the next phase of its growth.”, said Jan Rinnert, CEO and Chairman of the Board of Managing Directors.